Last edition
News about
Ono Announces Acquisition of Deciphera Pharmaceuticals
Ono Pharmaceutical, Co., Ltd. has completed the tender offer to acquire all outstanding shares of common stock of a US biopharmaceutical company, Deciphera Pharmaceuticals, Inc. for USD 25.60 per share (total amount of approximately USD 2.4 billion) net to the seller in cash.
AbbVie and FutureGen to Develop Next-Gen Therapy for Inflammatory Bowel Disease
AbbVie has signed a license agreement with FutureGen Biopharmaceutical to develop FG-M701, a next-generation TL1A antibody for the treatment of IBD currently in preclinical development.
Suven to Acquire Majority Stake in Sapala Organics
Suven Pharmaceuticals has signed a definitive agreement for a strategic controlling investment in Sapala Organics Private Ltd.
Xeltis Bags IDE Approval from FDA for Initiation of US Pivotal Trial for aXess
Xeltis announces that it has gained approval from the US Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) submission to begin enrolling patients into a pivotal study for aXess.
Prendio-BioProcure and Portal Innovations to Accelerate Life Science Innovation
Prendio-BioProcure has forged a strategic partnership with Portal Innovations, aimed at accelerating innovation and growth in the life science sector.
Clario Announces FDA Clearance for its SpiroSphere with Wireless COR-12 ECG Device
This technological advancement allows for the consecutive collection of spirometry and ECG data during a single site visit through Clario's SpiroSphere® platform, consolidating all data into a single, unified database.
NSG BioLabs and Eppendorf Group to Support Biotech Companies in Singapore
NSG BioLabs has collaborated with Eppendorf to support biotech startups by providing needed resources such as product and applications expertise and its networks to advance startup research and development (R&D).
Asahi Kasei Introduces Membrane System to Produce Water for Injection
Asahi Kasei has begun selling a membrane system to produce WFI (water for injection), a type of sterile water that is used for the preparation of injections.
Lupin Signs License and Supply Deal with Fuji for Commercialization of Nextstellis
Lupin has signed a license and supply agreement with OLIC (Thailand) LTD. (OLIC), a subsidiary of the renowned Japanese pharmaceutical company Fuji Pharma Co., Ltd. (Fuji), for marketing Nextstellis (drospirenone and estetrol tablets) in Vietnam and Philippines.
Charles River Laboratories, MatTek Receive Grant from FCRI to Advance Research Alternatives
Charles River Laboratories International, Inc. has announced a multidisciplinary program, funded through a USD 1.3 million grant from the Foundation for Chemistry Research & Initiatives (FCRI), in coordination with ACC LRI, to develop a New Approach Methodology (NAM) inhalation toxicology test to reduce reliance on traditional animal research methods.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy